Summary
Tumour-selective acidification is of potential interest for enhanced therapeutic gain of pH sensitive drugs. In this study, we investigated the feasibility of a tumour-selective reduction of the extracellular and intracellular pH and their effect on the tumour response of selected anti-cancer drugs. In an in vitro L1210 leukaemic cell model, we confirmed enhanced cytotoxicity of chlorambucil at low extracellular pH conditions. In contrast, the alkylating drugs melphalan and cisplatin, and bioreductive agents mitomycin C and its derivative EO9, required low intracellular pH conditions for enhanced activation. Furthermore, a strong and pH-independent synergism was observed between the pH-equilibrating drug nigericin and melphalan, of which the mechanism is unclear. In radiation-induced fibrosarcoma (RIF-1) tumour-bearing mice, the extracellular pH was reduced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) or its analogue benzylguanidine (BG) plus glucose. To simultaneously reduce the intracellular pH, MIBG plus glucose were combined with the ionophore nigericin or the Na+/H+exchanger inhibitor amiloride and the Na+-dependent HCO3–/Cl–exchanger inhibitor 4,4′-diisothiocyanostilbene-2,2′-disulphonic acid (DIDS). Biochemical studies confirmed an effective reduction of the extracellular pH to approximately 6.2, and anti-tumour responses to the interventions indicated a simultaneous reduction of the intracellular pH below 6.6 for at least 3 h. Combined reduction of extra- and intracellular tumour pH with melphalan increased the tumour regrowth time to 200% of the pretreatment volume from 5.7 ± 0.6 days for melphalan alone to 8.1 ± 0.7 days with pH manipulation (P< 0.05). Mitomycin C related tumour growth delay was enhanced by the combined interventions from 3.8 ± 0.5 to 5.2 ± 0.5 days (P< 0.05), but only in tumours of relatively large sizes. The interventions were non-toxic alone or in combination with the anti-cancer drugs and did not affect melphalan biodistribution. In conclusion, we have developed non-toxic interventions for sustained and selective reduction of extra- and intracellular tumour pH which potentiated the tumour responses to selected anti-cancer drugs.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alabaster, O., Woods, T., Ortiz-Sanchez, V. & Jahangeer, S. (1989). Influence of microenvironmental pH on adriamycin resistance. Cancer Res 49: 5638–5643.
Atema, A., Buurman, K. J. H., Noteboom, E. & Smets, L. A. (1993). Potentiation of DNA-adduct formation and cytotoxicity of platinum-containing drugs by low pH. Int J Cancer 54: 166–172.
Begleiter, A. & Leith, M. K. (1993). Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions. Mol Pharmacol 44: 210–215.
Bradford, M. M. (1976). A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254.
Dirix, L. Y., Tonnesen, F., Cassidy, J., Epelbaum, R., ten Bokkel Huinink, W. W., Pavlidis, N., Sorio, R., Gamucci, T., Wolff, I., te Velde, A., Lan, J. & Verwey, J. (1996). EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC early clinical studies group. Eur J Cancer 32: 2019–2022.
Evelhoch, J. L., Sapareto, S. A., Jick, D. E. L. & Ackerman, J. J. H. (1984). In vivo metabolic effects of hyperglycaemia in murine radiation-induced fibrosarcoma: a 31P NMR investigation. Proc Natl Acad Sci USA 81: 6496–6500.
Gabr, A., Kuin, A., Aalders, M., El-Gawly, H. & Smets, L. A. (1997). Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH. Cancer Res 57: 4811–4816.
Gibson, N. W., Siegel, D. & Ross, D. (1992). Mitomycin C. Cancer Chemother Biol Response Modif 13: 59–68.
Hwang, Y. C., Kim, S-G, Evelhoch, J. L., Seyedsadr, M. & Ackerman, J. J. H. (1991). Modulation of murine radiation-induced fibrosarcoma-1 tumor metabolism and blood flow in situ via glucose and mannitol administration monitored by 31P and 2H nuclear magnetic resonance spectroscopy. Cancer Res 51: 3108–3118.
Jähde, E. & Rajewsky, M. F. (1982). Tumor-selective modification of cellular microenvironment in vivo: effect of glucose infusion on the pH in normal and malignant rat tissues. Cancer Res 42: 1505–1512.
Jähde, E., Glüsenkamp, K-H, Klünder, I., Hülser, D. F., Tietze, L-F & Rajewsky, M. F. (1989). Hydrogen ion-mediated enhancement of cytotoxicity of bis-chloroethylating drugs in rat mammary carcinoma cells in vitro. Cancer Res 49: 2965–2972.
Klaase, J. M., Kroon, B. B. R., Beijnen, J. H., van Slooten, G. W. & van Dongen, J. A. (1994). Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb. Br J Cancer 70: 151–153.
Kuin, A., Smets, L., Volk, T., Paans, A., Adams, G., Atema, A., Jähde, E., Maas, A., Rajewsky, M. F., Visser, G. & Wood, P. (1994). Reduction of intratumoral pH by the mitochondrial inhibitor m-iodobenzylguanidine and moderate hyperglycaemia. Cancer Res 54: 3785–3792.
Kuin, A., Aalders, M., van der Valk, M. A., Frey, A., Schmidt, HHHW & Smets, L. A. (1998). Renal toxicity of the neuron-blocking and mitochondriotropic agent m-iodobenzylguanidine (MIBG). Cancer Chemother Pharmacol 42: 37–45.
Lee, F. Y. F., Coe, P. & Workman, P. (1986). Pharmacokinetic basis for the comparative antitumor activity and toxicity of chlormabucil, phenylacetic acid mustard and β,β-difluorochlorambucil (CB 7103) in mice. Cancer Chemother Pharmacol 17: 21–29.
Loesberg, C., van Rooij, H., Nooijen, W. J., Meijer, A. J. & Smets, L. A. (1990). Impaired mitochondrial respiration and stimulated glycolysis by m-iodobenzylguanidine (MIBG). Int J Cancer 46: 276–281.
Mansour, T. E. (1972). Phosphofructokinase. Curr Top Cell Regul 5: 1–46.
Mikkelsen, R. B., Asher, C. & Hicks, T. (1985). Extracellular pH, transmembrane distribution and cytotoxicity of chlorambucil. Biochem Pharmacol 34: 2531–2534.
Newell, K. J. & Tannock, I. F. (1989). Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: effects of carbonylcyanide-3-chlorophenylhydrazone. Cancer Res 49: 4477–4482.
Newell, K., Wood, P., Stratford, I. & Tannock, I. (1992). Effects of agents which inhibit the regulation of intracellular pH on murine solid tumours. Br J Cancer 66: 311–317.
Nishiyama, M., Suzuki, K., Kumazaki, T., Yamamoto, W., Toge, T., Okamura, T. & Kurisu, K. (1997). Molecular targeting of mitomycin C chemotherapy. Int J Cancer 72: 649–656.
Parkins, C. S., Chadwick, J. A. & Chaplin, D. J. (1994). Enhancement of chlorambucil cytotoxicity by combination with flavone acetic acid in a murine tumour. Anticancer Res 14: 1603–1608.
Philips, R. M., Hulbert, P. B., Bibby, M. C., Sleigh, N. R. & Double, J. A. (1992). In vitro activity of the novel indoloquinone EO-9 and the influence of pH on cytotoxicity. Br J Cancer 65: 359–364.
Rotin, D., Wan, P., Grinstein, S. & Tannock, I. (1987). Cytotoxicity of compounds that interfere with the regulation of intracellular pH: a potential new class of anticancer drugs. Cancer Res 47: 1497–1504.
Skarsgard, L. D., Chaplin, D. J., Wilson, D. J., Skwarchuk, M. W., Vinczan, A. & Kristl, J. (1992). The effect of hypoxia and low pH on the cytotoxicity of chlorambucil. J Radiat Oncol Biol Phys 22: 737–741.
Song, C. W., Kim, G. E., Lyons, J. C., Makepeace, C. M., Griffin, R. J., Rao, G. H. & Cragoe, E. J. (1994). Thermosensitization by increasing intracellular acidity with amiloride and its analogues. Int J Radiat Oncol Biol Phys 30: 1161–1169.
Thislethwaite, A. J., Alexander, G. A., Moylan, III D. J. & Leeper, D. B. (1987). Modification of human tumor pH by elevation of blood glucose. Int J Radiat Oncol Biol Phys 13: 603–610.
Tietze, L. F., Neumann, M., Möllers, T., Fischer, R., Glüsenkamp, K-H, Rajewsky, M. F. & Jähde, E. (1989). Proton-mediated liberation of aldophosphamide from a nontoxic prodrug: a strategy for tumor-selective activation of cytocical drugs. Cancer Res 49: 4179–4184.
Twentyman, P. R., Brown, J. M., Gray, J. W., Franko, A. J., Scoles, M. A. & Kallman, R. F. (1980). A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst 64: 595–604.
Van den Berg, J. D., Smets, L. A., Rutgers, M., Grummels, A., Fokkens, R., Jonkergauw, P. & van Rooij, H. (1997). Chemical characterization and comparative cellular effects of meta-iodobenzyl guanidine and benzyl guanidine. Cancer Chemother Pharmacol 40: 131–137.
Vaupel, P., Kallinowski, F. & Okunieff, P. (1989). Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449–6465.
Volk, T., Jähde, E., Fortmeyer, H. P., Glüsenkamp, K-H & Rajewsky, M. F. (1993). pH in human tumour xenografts: effect of intravenous administration of glucose. Br J Cancer 68: 492–500.
Wike-Hooley, J. L., Haveman, J. & Reinhold, H. S. (1984). The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol 2: 343–366.
Wood, P. J., Sansom, J. M., Newell, K., Tannock, I. F. & Stratford, I. J. (1995). Reduction of tumour intracellular pH and enhancement of melphalan cytotoxicity by the ionophore nigericin. Int J Cancer 60: 264–268.
Yamagata, M. & Tannock, I. F. (1996). The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects. Br J Cancer 73: 1328–1334.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Kuin, A., Aalders, M., Lamfers, M. et al. Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG). Br J Cancer 79, 793–801 (1999). https://doi.org/10.1038/sj.bjc.6690127
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690127
Keywords
This article is cited by
-
Relative contributions of mitochondria and NADPH oxidase to deoxycorticosterone acetate-salt hypertension in mice
Kidney International (2011)
-
The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis
Nature Reviews Cancer (2005)
-
Effects of tumour acidification with glucose+MIBG on the spontaneous metastatic potential of two murine cell lines
British Journal of Cancer (2004)